Table 1.
Summary of clinical characteristics in 40 patients with pancreatic cancer
| Number | Percentage | HMGB1high [n (%)] | |
|---|---|---|---|
| Patients | 40 | 32 (80) | |
| Gender | |||
| Male | 28 | 70 | 23 (57.5) |
| Female | 12 | 30 | 9 (22.5) |
| Age | |||
| Median | 56 | ||
| Range | 34–75 | ||
| ≤ 50 y | 16 | 40 | 11 (27.5) |
| >50 y | 24 | 60 | 21 (52.5) |
| TNM stage | |||
| Stage I | 3 | 7.5 | 1 (2.5) |
| Stage II | 14 | 35 | 7 (17.5) |
| Stage III | 17 | 42.5 | 16 (40) |
| Stage IV | 6 | 15 | 6 (15) |
| Lymph nodes | |||
| Positive | 9 | 22.5 | 8 (20) |
| Negative | 31 | 77.5 | 6 (15) |
| Distance metastasis | |||
| Positive | 6 | 15 | 6 (15) |
| Negative | 34 | 85 | 8 (22.5) |
| Response to therapy | |||
| Partial response + stable disease | 6 | 15 | 2 (5) |
| Progressive disease | 29 | 72.5 | 25 (62.5) |
| Not assessed | 5 | 12.5 | |